5 Einträge gefunden

1. Impact of molecular residual disease post allografting in myelofibrosis patients

   1. Wolschke, C
   2. Badbaran, A
   3. Zabelina, T
   4. Christopeit, M
   5. Ayuketang, Francis Ayuk
   6. Triviai, I
   7. Zander, A

   2017 - Forschungsinformationssystem des UKE
2. Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis

   1. Alchalby, H
   2. Yunus, D-R
   3. Zabelina, Tatiana
   4. Ayuketang, Francis Ayuk
   5. Kröger, Nicolaus-Martin

   2016 - Forschungsinformationssystem des UKE
3. Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation

   1. Wolschke, C
   2. Zabelina, T
   3. Ayuketang, Francis Ayuk
   4. Alchalby, H
   5. Berger, Juergen
   6. Klyuchnikov, E
   7. Pein, U-M

   2014 - Forschungsinformationssystem des UKE
4. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

   1. Stübig, T
   2. Alchalby, H
   3. Ditschkowski, M
   4. Wolf, D
   5. Wulf, G
   6. Zabelina, T
   7. Wolschke, C

   2014 - Forschungsinformationssystem des UKE
5. Donor choice according to age for allo-SCT for AML in complete remission

   1. Ayuketang, Francis Ayuk
   2. Zabelina, T
   3. Wortmann, F
   4. Alchalby, H
   5. Wolschke, C
   6. Lellek, H
   7. Bacher, U

   2013 - Forschungsinformationssystem des UKE